Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boostrix Booster Safety in Chinese Children
NCT00406562Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) in Tetanus, diphtheria, pertussis, sponsored by GSK. Started Jan 2007; status: completed.
02
Drugs
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)
03
Conditions
Tetanusdiphtheriapertussis
Beyond the preview
Go deeper on NCT00406562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00406562.